Admin-Core-001

管理核心-001

• 批准号: 10709107
• 负责人: GRAHAM A. COLDITZ
• 金额: $ 2.85万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10709107
• 关键词: Admin; Core; 001

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research. Our focus is on rare and understudied cancer populations with significant disparities including cholangiocarcinoma, multiple myeloma, and colorectal cancer under age 50. Participant engagement strategies are most effective when they are adapted and implemented in real-world settings in partnership with community and patient advocacy stakeholders.

WU-PE-CGS的总体目标是为癌症患者和治疗后癌症幸存者直接参与癌症研究的方法建立严格的科学证据基础。我们的重点是罕见和研究不足的癌症人群，包括胆管癌，多发性骨髓瘤和50岁以下的结直肠癌。参与者参与战略是最有效的，当他们适应和实施在现实世界中与社区和病人的利益相关者的伙伴关系。